Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future Prospects

mRNA vaccines encoding tumor antigens may be able to sensitize the immune system of the host against cancer cells, enhancing antigen presentation and immune response. Since the breakout of the COVID19 pandemic, interest in mRNA vaccines has been accelerating, as vaccination against the virus served...

Full description

Bibliographic Details
Published in:	Vaccines
Main Authors:	Dimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas, George Samonis
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Subjects:	mRNA vaccines melanoma cancer immunotherapy
Online Access:	https://www.mdpi.com/2076-393X/11/3/636

Similar Items

Individualized mRNA Vaccines in Melanoma—Where Do We Stand?
by: Ioanna Gazouli, et al.
Published: (2025-09-01)

Therapeutic Effect of mRNA SARS-CoV-2 Vaccine on Melanoma Skin Metastases
by: Dimitrios Bafaloukos, et al.
Published: (2022-03-01)

Intratumoral administration of mRNA COVID-19 vaccine delays melanoma growth in mice
by: Dylan T. Boehm, et al.
Published: (2025-02-01)

Next-Generation mRNA Vaccines in Melanoma: Advances in Delivery and Combination Strategies
by: Stefano Zoroddu, et al.
Published: (2025-09-01)

mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic
by: Ziyang Xu, et al.
Published: (2023-03-01)

Severe Gastritis Due to Nivolumab Treatment of a Metastatic Melanoma Patient
by: George Samonis, et al.
Published: (2022-11-01)

The Recent Research Progress of the Tumor mRNA Vaccine
by: Hao Zhao, et al.
Published: (2024-10-01)

mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
by: Maryam Bidram, et al.
Published: (2021-09-01)

Advancements in mRNA Encoded Antibodies for Passive Immunotherapy
by: Cailin E. Deal, et al.
Published: (2021-01-01)

The Application of mRNA Technology for Vaccine Production—Current State of Knowledge
by: Anna Paczkowska, et al.
Published: (2025-04-01)

mRNA vaccine in cancer therapy: Current advance and future outlook
by: Youhuai Li, et al.
Published: (2023-08-01)

Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy
by: Yuxiang Zhao, et al.
Published: (2023-10-01)

Advances in mRNA vaccine therapy for breast cancer research
by: Jia-ying Li, et al.
Published: (2025-05-01)

Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy
by: Theodora Katopodi, et al.
Published: (2024-03-01)

mRNA‐based chimeric antigen receptor T cell therapy: Basic principles, recent advances and future directions
by: Kaiting Xiao, et al.
Published: (2024-01-01)

Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunity
by: Hector R. Mendez-Gomez, et al.
Published: (2025-12-01)

Stimuli-responsive nanomaterials for the precision delivery of mRNA cancer vaccines
by: Ruby Srivastava
Published: (2025-09-01)

mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
by: Alireza Shariati, et al.
Published: (2024-12-01)

mRNA vaccine for cancer immunotherapy
by: Lei Miao, et al.
Published: (2021-02-01)

Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics
by: Wei Yang, et al.
Published: (2023-05-01)

Advancing mRNA technologies for therapies and vaccines: An African context
by: Dylan Kairuz, et al.
Published: (2022-10-01)

Emerging prospects of mRNA cancer vaccines: mechanisms, formulations, and challenges in cancer immunotherapy
by: Umm E. Laila, et al.
Published: (2024-11-01)

mRNA, a Revolution in Biomedicine
by: Bruno Baptista, et al.
Published: (2021-12-01)

Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy
by: Hong-Li Wang, et al.
Published: (2022-08-01)

Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024-12-01)

Efficient mRNA Delivery with mRNA Lipoplexes Prepared Using a Modified Ethanol Injection Method
by: Min Tang, et al.
Published: (2023-04-01)

From structural design to delivery: mRNA therapeutics for cancer immunotherapy
by: Feng Zhou, et al.
Published: (2024-04-01)

PEGylation of mRNA by Hybridization of Complementary PEG-RNA Oligonucleotides Stabilizes mRNA without Using Cationic Materials
by: Naoto Yoshinaga, et al.
Published: (2021-05-01)

Bioinformatics analysis reveals novel tumor antigens and immune subtypes of skin cutaneous melanoma contributing to mRNA vaccine development
by: Ronghua Yang, et al.
Published: (2025-02-01)

Emerging Immunotherapies in Lung Cancer: The Latest Advances and the Future of mRNA Vaccines
by: Raquel Ramos, et al.
Published: (2025-04-01)

Preclinical development of an mRNA-based multiepitope immunotherapeutic for glioblastoma
by: Johannes Lutz, et al.
Published: (2025-10-01)

Progress and challenges of mRNA vaccines
by: Liangru Lin, et al.
Published: (2023-01-01)

mRNA-Based Therapeutics in Cancer Treatment
by: Han Sun, et al.
Published: (2023-02-01)

Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy
by: Yusi Wang, et al.
Published: (2022-02-01)

Messenger RNA (mRNA) based therapeutics in transforming cardiovascular care: Progress, regulatory challenges and future perspectives
by: Mudassir Khan, et al.
Published: (2025-08-01)

CleanCap M6 inhibits decapping of exogenously delivered IVT mRNA
by: Zachary F. Mandell, et al.
Published: (2025-03-01)

Research progress on the quality control of mRNA vaccines
by: Chaoying Hu, et al.
Published: (2024-12-01)

An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model
by: Srdan Tadic, et al.
Published: (2025-06-01)

Modified mRNA Formulation and Stability for Cardiac and Skeletal Muscle Delivery
by: Magdalena M. Żak, et al.
Published: (2023-08-01)

mRNA vaccines: Past, present, future
by: Mia Karam, et al.
Published: (2022-07-01)